Market Cap 159.36M
Revenue (ttm) 1.55M
Net Income (ttm) -63.06M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -4,068.39%
Debt to Equity Ratio 0.00
Volume 867,800
Avg Vol 1,414,754
Day's Range N/A - N/A
Shares Out 124.50M
Stochastic %K 57%
Beta 0.97
Analysts Strong Sell
Price Target $6.33

Company Profile

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. It offers CARDAMYST (etripamil) nasal spray, a prescription medication for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. The company is also developing etripamil for the indication of atrial fibrillation with rapid ventricular rate (AFib-RVR). It has a...

Industry: Biotechnology
Sector: Healthcare
Phone: 514 336 0444
Address:
1111 Dr. Frederik-Philips Boulevard, Suite 420, Montreal, Canada
okacser
okacser Jul. 15 at 1:28 PM
$SLS @BioRich I FEEL YOU! YOU HAVE HAD SOLID THESES BOTH WITH $MIST AND $SLS. BUT THERE ARE OTHER BLUNDERS. YOU ADVOCATED FOR $GUTS AND LOOK AT THE SP. ALL TIME LOWS. TOO MANY CASES TO EXPLAIN. PEOPLE OF $GUTS ARE SAD FOR YOU!
2 · Reply
aak12345
aak12345 Jul. 15 at 1:16 PM
$MIST what warrants expiration takes away is constant selling pressure on any positive development.
0 · Reply
soccerfan913
soccerfan913 Jul. 15 at 12:31 PM
$MIST This warrant expiration is going to be a fairly non-event. What the dilution gives, the additional revenue for the company takes away. I'll be surprised if we see much more then a few cents either way.
1 · Reply
okacser
okacser Jul. 15 at 11:11 AM
$SLS @BioRich MY MAN! I RESPECT YOU BECAUSE YOU HAVE SOLID OPINION. THAT SAID, I ALSO REMEMBER YOUR BULL CRUSADE WITH $MIST LAST DECEMBER, WHEN FDA APPROVAL CAME. YOU FIRMLY BELIEVED THE STOCK WOULD 4X FROM THE CURRENT LVL (3 USD), AND WHAT HAPPENED? DEEP DIVE. JUST LOOK AT THE GRAPH. NEVER REACHED EVEN 2.5 FOR A YEAR. I LEARNED THAT THE FORMULA FOR MAKING MONEY ON BIOTECH STOCKS IS VERY SIMPLE: LISTEN TO BIORICH => DO THE OPPOSITE
4 · Reply
stockman333699
stockman333699 Jul. 15 at 4:34 AM
$MIST ....Needs to start Moving
0 · Reply
okacser
okacser Jul. 15 at 12:52 AM
$MIST warrants expired. We will see 1,32 USD soon. So excited
1 · Reply
Diverstj981
Diverstj981 Jul. 14 at 8:41 PM
$MIST Series A warrants 👇👇👇👇👇
1 · Reply
stockman333699
stockman333699 Jul. 14 at 6:47 PM
$MIST ...I am A Glutton For Punishment....Bought some at 1.28.6
4 · Reply
stockman333699
stockman333699 Jul. 14 at 5:55 PM
$MIST ...Looks Like those July 14 1.50 Warrent Will Expire Worthless
0 · Reply
BigFishLittleCompany
BigFishLittleCompany Jul. 14 at 5:53 PM
$MIST HERE WE GO
0 · Reply
Latest News on MIST
Milestone Pharmaceuticals Slides: Corporate presentation

Jun 1, 2026, 7:00 AM EDT - 6 weeks ago

Milestone Pharmaceuticals Slides: Corporate presentation


Milestone Pharmaceuticals files $300M mixed securities shelf

2026-05-13T21:54:39.000Z - 2 months ago

Milestone Pharmaceuticals files $300M mixed securities shelf


Milestone Pharmaceuticals reports Q1 EPS (20c), consensus 19c

2026-05-13T12:41:15.000Z - 2 months ago

Milestone Pharmaceuticals reports Q1 EPS (20c), consensus 19c


Milestone Pharmaceuticals Earnings Call Transcript: Q1 2026

May 13, 2026, 8:30 AM EDT - 2 months ago

Milestone Pharmaceuticals Earnings Call Transcript: Q1 2026


Milestone Pharmaceuticals Quarterly report: Q1 2026

May 13, 2026, 8:30 AM EDT - 2 months ago

Milestone Pharmaceuticals Quarterly report: Q1 2026


Milestone Pharmaceuticals Earnings release: Q1 2026

May 13, 2026, 8:30 AM EDT - 2 months ago

Milestone Pharmaceuticals Earnings release: Q1 2026


Milestone Pharmaceuticals Slides: Corporate presentation

May 13, 2026, 7:00 AM EDT - 2 months ago

Milestone Pharmaceuticals Slides: Corporate presentation


Milestone Pharmaceuticals Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 2 months ago

Milestone Pharmaceuticals Proxy statement: Proxy filing


Milestone Pharmaceuticals Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 2 months ago

Milestone Pharmaceuticals Proxy statement: Proxy filing


Milestone Pharmaceuticals Slides: Corporate presentation

Apr 14, 2026, 7:00 AM EDT - 3 months ago

Milestone Pharmaceuticals Slides: Corporate presentation


Milestone Pharmaceuticals provides details on RESET-PSVT trial

2026-04-10T12:06:08.000Z - 3 months ago

Milestone Pharmaceuticals provides details on RESET-PSVT trial


Milestone Pharmaceuticals Earnings Call Transcript: Q4 2025

Mar 20, 2026, 8:30 AM EDT - 4 months ago

Milestone Pharmaceuticals Earnings Call Transcript: Q4 2025


Milestone Pharmaceuticals Earnings release: Q4 2025

Mar 20, 2026, 8:30 AM EDT - 4 months ago

Milestone Pharmaceuticals Earnings release: Q4 2025


Milestone Pharmaceuticals Annual report: Q4 2025

Mar 20, 2026, 8:30 AM EDT - 4 months ago

Milestone Pharmaceuticals Annual report: Q4 2025


Milestone Pharmaceuticals reports Q4 EPS (16c), consensus (18c)

2026-03-20T11:21:41.000Z - 4 months ago

Milestone Pharmaceuticals reports Q4 EPS (16c), consensus (18c)


Milestone Pharmaceuticals to present Cardamyst data at ACC 26

2026-03-16T12:23:37.000Z - 4 months ago

Milestone Pharmaceuticals to present Cardamyst data at ACC 26


Milestone Pharmaceuticals Slides: Corporate presentation

Feb 6, 2026, 7:00 AM EST - 5 months ago

Milestone Pharmaceuticals Slides: Corporate presentation


Milestone Pharmaceuticals upgraded to Buy from Hold at TD Cowen

2025-12-15T15:05:16.000Z - 7 months ago

Milestone Pharmaceuticals upgraded to Buy from Hold at TD Cowen


Milestone Pharmaceuticals Transcript: FDA Announcement

Dec 15, 2025, 8:00 AM EST - 7 months ago

Milestone Pharmaceuticals Transcript: FDA Announcement


Milestone Pharmaceuticals Press release: FDA Announcement

Dec 15, 2025, 8:00 AM EST - 7 months ago

Milestone Pharmaceuticals Press release: FDA Announcement


Milestone Pharmaceuticals Slides: FDA Announcement

Dec 15, 2025, 8:00 AM EST - 7 months ago

Milestone Pharmaceuticals Slides: FDA Announcement


Milestone Pharmaceuticals receives FDA approval of CARDAMYST

2025-12-14T16:30:25.000Z - 7 months ago

Milestone Pharmaceuticals receives FDA approval of CARDAMYST


Milestone Pharmaceuticals Earnings release: Q3 2025

Nov 12, 2025, 7:00 AM EST - 8 months ago

Milestone Pharmaceuticals Earnings release: Q3 2025


Milestone Pharmaceuticals Quarterly report: Q3 2025

Nov 12, 2025, 7:00 AM EST - 8 months ago

Milestone Pharmaceuticals Quarterly report: Q3 2025


Milestone Pharmaceuticals Slides: Company Presentation

Nov 12, 2025, 7:00 AM EST - 8 months ago

Milestone Pharmaceuticals Slides: Company Presentation


Milestone® Pharmaceuticals to Present at Upcoming Conferences

Aug 19, 2025, 8:00 AM EDT - 11 months ago

Milestone® Pharmaceuticals to Present at Upcoming Conferences


Milestone Pharmaceuticals Earnings release: Q2 2025

Aug 12, 2025, 7:00 AM EDT - 1 year ago

Milestone Pharmaceuticals Earnings release: Q2 2025


Milestone Pharmaceuticals Quarterly report: Q2 2025

Aug 12, 2025, 7:00 AM EDT - 1 year ago

Milestone Pharmaceuticals Quarterly report: Q2 2025


Milestone Pharmaceuticals Announces Proposed Public Offering

Jul 11, 2025, 6:01 AM EDT - 1 year ago

Milestone Pharmaceuticals Announces Proposed Public Offering


Milestone Pharmaceuticals Earnings release: Q1 2025

May 14, 2025, 7:00 AM EDT - 1 year ago

Milestone Pharmaceuticals Earnings release: Q1 2025


Milestone Pharmaceuticals Quarterly report: Q1 2025

May 14, 2025, 7:00 AM EDT - 1 year ago

Milestone Pharmaceuticals Quarterly report: Q1 2025


Milestone Pharmaceuticals Proxy statement: Proxy Filing

Apr 30, 2025, 8:00 AM EDT - 1 year ago

Milestone Pharmaceuticals Proxy statement: Proxy Filing


Milestone Pharmaceuticals Proxy statement: Proxy Filing

Apr 30, 2025, 8:00 AM EDT - 1 year ago

Milestone Pharmaceuticals Proxy statement: Proxy Filing


FDA Issues Complete Response Letter for Etripamil for PSVT

Mar 28, 2025, 7:00 AM EDT - 1 year ago

FDA Issues Complete Response Letter for Etripamil for PSVT


Milestone Pharmaceuticals Annual report: Q4 2024

Mar 13, 2025, 7:00 AM EDT - 1 year ago

Milestone Pharmaceuticals Annual report: Q4 2024


Milestone Pharmaceuticals Earnings release: Q4 2024

Mar 13, 2025, 7:00 AM EDT - 1 year ago

Milestone Pharmaceuticals Earnings release: Q4 2024


Milestone Pharmaceuticals Transcript: Investor update

Feb 25, 2025, 10:30 AM EST - 1 year ago

Milestone Pharmaceuticals Transcript: Investor update


Milestone Pharmaceuticals Slides: Investor update

Feb 25, 2025, 10:30 AM EST - 1 year ago

Milestone Pharmaceuticals Slides: Investor update


Milestone Pharmaceuticals Earnings release: Q3 2024

Nov 12, 2024, 8:00 AM EST - 1 year ago

Milestone Pharmaceuticals Earnings release: Q3 2024


Milestone Pharmaceuticals Slides: Corporate Presentation

Nov 12, 2024, 8:00 AM EST - 1 year ago

Milestone Pharmaceuticals Slides: Corporate Presentation


Milestone Pharmaceuticals Earnings release: Q2 2024

Aug 8, 2024, 8:00 AM EDT - 2 years ago

Milestone Pharmaceuticals Earnings release: Q2 2024


Milestone Pharmaceuticals Proxy statement: Proxy Filing

Jul 15, 2024, 8:00 AM EDT - 2 years ago

Milestone Pharmaceuticals Proxy statement: Proxy Filing


Milestone Pharmaceuticals Proxy statement: Proxy Filing

Jul 15, 2024, 8:00 AM EDT - 2 years ago

Milestone Pharmaceuticals Proxy statement: Proxy Filing


Milestone Pharmaceuticals Proxy statement: Proxy Filing

Jul 15, 2024, 8:00 AM EDT - 2 years ago

Milestone Pharmaceuticals Proxy statement: Proxy Filing


Milestone Pharmaceuticals Transcript: Study update

Jun 20, 2024, 8:00 AM EDT - 2 years ago

Milestone Pharmaceuticals Transcript: Study update


Milestone Pharmaceuticals Earnings release: Q1 2024

May 13, 2024, 8:00 AM EDT - 2 years ago

Milestone Pharmaceuticals Earnings release: Q1 2024


Milestone Pharmaceuticals Annual report: Q4 2023

Mar 21, 2024, 9:00 AM EDT - 2 years ago

Milestone Pharmaceuticals Annual report: Q4 2023


Milestone Pharmaceuticals Earnings release: Q4 2023

Mar 21, 2024, 9:00 AM EDT - 2 years ago

Milestone Pharmaceuticals Earnings release: Q4 2023


okacser
okacser Jul. 15 at 1:28 PM
$SLS @BioRich I FEEL YOU! YOU HAVE HAD SOLID THESES BOTH WITH $MIST AND $SLS. BUT THERE ARE OTHER BLUNDERS. YOU ADVOCATED FOR $GUTS AND LOOK AT THE SP. ALL TIME LOWS. TOO MANY CASES TO EXPLAIN. PEOPLE OF $GUTS ARE SAD FOR YOU!
2 · Reply
aak12345
aak12345 Jul. 15 at 1:16 PM
$MIST what warrants expiration takes away is constant selling pressure on any positive development.
0 · Reply
soccerfan913
soccerfan913 Jul. 15 at 12:31 PM
$MIST This warrant expiration is going to be a fairly non-event. What the dilution gives, the additional revenue for the company takes away. I'll be surprised if we see much more then a few cents either way.
1 · Reply
okacser
okacser Jul. 15 at 11:11 AM
$SLS @BioRich MY MAN! I RESPECT YOU BECAUSE YOU HAVE SOLID OPINION. THAT SAID, I ALSO REMEMBER YOUR BULL CRUSADE WITH $MIST LAST DECEMBER, WHEN FDA APPROVAL CAME. YOU FIRMLY BELIEVED THE STOCK WOULD 4X FROM THE CURRENT LVL (3 USD), AND WHAT HAPPENED? DEEP DIVE. JUST LOOK AT THE GRAPH. NEVER REACHED EVEN 2.5 FOR A YEAR. I LEARNED THAT THE FORMULA FOR MAKING MONEY ON BIOTECH STOCKS IS VERY SIMPLE: LISTEN TO BIORICH => DO THE OPPOSITE
4 · Reply
stockman333699
stockman333699 Jul. 15 at 4:34 AM
$MIST ....Needs to start Moving
0 · Reply
okacser
okacser Jul. 15 at 12:52 AM
$MIST warrants expired. We will see 1,32 USD soon. So excited
1 · Reply
Diverstj981
Diverstj981 Jul. 14 at 8:41 PM
$MIST Series A warrants 👇👇👇👇👇
1 · Reply
stockman333699
stockman333699 Jul. 14 at 6:47 PM
$MIST ...I am A Glutton For Punishment....Bought some at 1.28.6
4 · Reply
stockman333699
stockman333699 Jul. 14 at 5:55 PM
$MIST ...Looks Like those July 14 1.50 Warrent Will Expire Worthless
0 · Reply
BigFishLittleCompany
BigFishLittleCompany Jul. 14 at 5:53 PM
$MIST HERE WE GO
0 · Reply
Jdheart101
Jdheart101 Jul. 14 at 5:42 PM
$MIST shorts gonna have to cover soon, squeeze coming
0 · Reply
CashisKing_
CashisKing_ Jul. 14 at 4:36 PM
$MIST we sure are stuck at this $1.30 mark aren’t we?
0 · Reply
nasser2254
nasser2254 Jul. 14 at 3:41 PM
$MIST this is pos stock well controlled by someone or buy institution, buy still holding for long time
0 · Reply
Idgaf1972
Idgaf1972 Jul. 14 at 3:20 PM
$MIST Hello everyone. Someone posted the following in Yahoo Finance. It’s interesting but no surprising. Again, patience is all that’s needed with this stock: “Saw my electrophysiology yesterday, I asked for the prescription, he was reluctant to give it to me said he could do another ablation and I would not have to take anything . Same song and dance I heard the first time , burned my heart twice it did not work. I told him I wanted to try Cardamyst , he finally agreed then told me I would be his first patient he has prescribed it for , also said yes it works he had participated in the trial. Even tried to convince me it was too expensive and my insurance might not cover it. I believe they don’t want to prescribe because money made on ablation.”
5 · Reply
Arxidia
Arxidia Jul. 14 at 2:51 PM
$MIST starting tomorrow the toxic algos should reset to zero and my once fav donkey should at least pop its head above cash position by eom, $1.50+ Holding till buyout $6.50+ Q1/Q2 27.
0 · Reply
nasser2254
nasser2254 Jul. 14 at 12:46 PM
$MIST holding for 7.
1 · Reply
PortfolioMgmt23
PortfolioMgmt23 Jul. 14 at 12:23 PM
$MIST POOF! And the series A warrants have disappeared!
1 · Reply
alexpitti
alexpitti Jul. 14 at 3:36 AM
$MIST short interest has been rising sharply recently. it's up from 10.6 million to 12.6 million.
2 · Reply
walkingonathinline
walkingonathinline Jul. 14 at 12:14 AM
$MIST when id this going to move ?
2 · Reply
BiotekInvestor
BiotekInvestor Jul. 14 at 12:07 AM
$MIST One day more!
0 · Reply
TheYoungGeologist
TheYoungGeologist Jul. 13 at 9:10 PM
$MIST does this sum up current PBM coverage correctly?
0 · Reply
KilroyPicks
KilroyPicks Jul. 13 at 8:11 PM
$MIST - FDA-approved nasal spray for PSVT (sudden rapid heartbeat episodes). It is self-administered. CVS Caremark provides prescription drug coverage for this medication. Because Cardamyst is a new and specialized drug, you must take these steps to get it filled at CVS:Coverage Rules: The drug requires prior authorization. This means your doctor must tell your health plan why you need it. Out-of-Pocket Cost: Without insurance, it costs over $1,700 per package.Copay Assistance: Eligible patients with commercial insurance may pay as little as $25 per prescription.
1 · Reply